The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.
This review critically evaluates the therapeutic role of cannabis medicinal products osteoarthritis management. It focuses on clinical evidence and efficacy of various pharmacological doses and forms. The findings highlight potential benefits and safety…
Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis Extract
This randomized clinical trial demonstrates that full-spectrum cannabis osteoarthritis pain relief is significant compared to placebo. The study provides controlled evidence supporting cannabinoid analgesic effects in degenerative joint disease. These…
Does oral cannabidiol oil in adjunct to pain medications help reduce pain and improve locomotion in dogs with osteoarthritis?
Oral cannabidiol oil osteoarthritis dogs is studied as an adjunct to conventional pain medications. Evidence suggests it may help reduce pain and improve locomotion in dogs with osteoarthritis. This research supports cautious optimism while awaiting…
![[Low-grade inflammation in musculoskeletal disorders: biological basis and role of PRGF].](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/04/tmp98vtqu6o.jpg?resize=440%2C310&ssl=1 "Low-Grade Inflammation in Musculoskeletal Disorders: Biological Basis and PRGF Role")
Low-Grade Inflammation in Musculoskeletal Disorders: Biological Basis and PRGF Role
Low-grade inflammation musculoskeletal disorders are increasingly recognized as inflammatory rather than purely degenerative. PRGF therapy targets this inflammation to promote tissue repair and pain relief. Understanding this biological basis is key to…
Small Pilot Study Tests Probiotics Plus PEA for Osteoarthritis Pain — Promising Signs for Function, Weak Pain Signal
This small multiple-baseline study suggests that a probiotics plus PEA osteoarthritis pain regimen may support function and wellbeing in some individuals with OA. The study found promising signs for function but only weak evidence for pain relief. These…
Tiny Pilot Study Hints at Possible Benefits of Probiotics Plus PEA for Osteoarthritis—But Far Too Early to Draw Conclusions
This pilot study investigates probiotics PEA osteoarthritis pain in four participants. Only one showed clear pain reduction, though functional and wellbeing improvements appeared more broadly. The findings are preliminary and highlight the need for…
Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral
This randomized and blind evaluation investigates the efficacy of full-spectrum oral cannabis extract for chronic osteoarthritis pain. The study provides clinical evidence on pain relief potential. Results highlight the importance of full-spectrum oral…
Therapeutic use of cannabinoids in age-related pain: Current evidence and clinical perspectives.
The therapeutic use of cannabinoids in age-related pain offers promising alternatives for older adults suffering from chronic conditions. This approach targets underlying inflammation and pain mechanisms unique to aging. Current evidence supports…
Probiotics and Palmitoylethanolamide (PEA) for Osteoarthritic Pain: Individual Effects Study
Palmitoylethanolamide osteoarthritis pain management shows promise in recent research. This study used a multiple baseline design to assess PEA and probiotics individually. Findings highlight potential anti-inflammatory benefits for chronic OA pain.
Understanding the Effects and Safety of CBD-Rich Therapies
Osteoarthritis is a common inflammatory and degenerative joint disease characterized by chronic pain. This article reviews the effects and safety of a CBD-rich treatment for osteoarthritis. Clinical trials suggest CBD may offer a safer alternative for…